Condition: Migraine Disorders · Sponsor: Upsher-Smith Laboratories
A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.
This description comes directly from the study's public registry record.
PPD Laboratories · 1-877-302-2879 · uslinfo@upsher-smith.com
Always discuss trial participation with your own doctor first.
| Upsher-Smith Clinical Trial Site #5 | Birmingham, Alabama, United States | Withdrawn |
| Upsher-Smith Clinical Trial Site #15 | La Jolla, California, United States | Recruiting |
| Upsher-Smith Clinical Trials Site #3 | Aurora, Colorado, United States | Withdrawn |
| Upsher-Smith Clinical Trial Site #1 | Stamford, Connecticut, United States | Completed |
| Upsher-Smith Clinical Trial Site #12 | Loxahatchee Groves, Florida, United States | Withdrawn |
| Upsher-Smith Clinical Trial Site #8 | Orlando, Florida, United States | Withdrawn |
| Upsher-Smith Clinical Trial Site #14 | Tampa, Florida, United States | Recruiting |
| Upsher-Smith Clinical Trial Site #2 | Ann Arbor, Michigan, United States | Withdrawn |
| Upsher-Smith Clinical Trial Site #11 | Jackson, Mississippi, United States | Withdrawn |
| Upsher-Smith Clinical Trial Site #10 | Bridgeton, Missouri, United States | Withdrawn |
| Upsher-Smith Clinical Trial Site #4 | Cincinnati, Ohio, United States | Recruiting |
| Upsher-Smith Clinical Trial Site #6 | Portland, Oregon, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04748601